Hai M Nguyen Selected Research

Kv1.3 Potassium Channel

12/2021	Kv1.3 inhibition attenuates neuroinflammation through disruption of microglial calcium signaling.
1/2018	Inhibition of the potassium channel Kv1.3 reduces infarction and inflammation in ischemic stroke.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Hai M Nguyen Research Topics

Disease

5	Alzheimer Disease (Alzheimer's Disease) 12/2021 - 01/2017
5	Neuroinflammatory Diseases 12/2021 - 12/2016
4	Autoimmune Diseases (Autoimmune Disease) 08/2020 - 09/2014
3	Ischemic Stroke 12/2021 - 01/2017
2	Inflammation (Inflammations) 11/2020 - 01/2018
2	Infarction (Infarctions) 01/2018 - 12/2016
2	Stroke (Strokes) 07/2017 - 12/2016
1	Spinocerebellar Ataxias (Spinocerebellar Ataxia) 01/2022
1	Ataxia (Dyssynergia) 01/2022
1	Cerebellar Ataxia (Dysmetria) 01/2022
1	Parkinson Disease (Parkinson's Disease) 12/2021
1	Traumatic Brain Injuries (Traumatic Brain Injury) 12/2021
1	Sickle Cell Anemia (Hemoglobin S Disease) 04/2019
1	Hypoxia (Hypoxemia) 01/2018
1	Epilepsy (Aura) 07/2017
1	Animal Disease Models 07/2017
1	Neurodegenerative Diseases (Neurodegenerative Disease) 07/2017
1	Middle Cerebral Artery Infarction (Middle Cerebral Artery Syndrome) 12/2016
1	Ischemia 12/2016
1	Pain (Aches) 01/2015
1	Acute Pain 01/2015
1	Tremor (Tremors) 04/2014
1	Colorectal Neoplasms (Colorectal Cancer) 03/2013
1	Experimental Autoimmune Encephalomyelitis (Encephalomyelitis, Autoimmune Experimental) 06/2012
1	Multiple Sclerosis 06/2012

Drug/Important Bio-Agent (IBA)

4	Potassium Channels (Potassium Channel)IBA 01/2021 - 12/2016
2	PotassiumIBA 01/2022 - 09/2014
2	Kv1.3 Potassium ChannelIBA 12/2021 - 01/2018
2	Amyloid (Amyloid Fibrils)IBA 04/2019 - 01/2018
2	Peptides (Polypeptides)IBA 09/2014 - 06/2012
1	CalciumIBA 01/2022
1	Pharmaceutical PreparationsIBA 01/2022
1	Large-Conductance Calcium-Activated Potassium Channels (Maxi-K Channels)IBA 01/2022
1	Calcibiotic Root Canal SealerIBA 01/2022
1	NS 1619IBA 01/2022
1	Purinergic P2X4 ReceptorsIBA 11/2020
1	AntigensIBA 08/2020
1	senicapocIBA 04/2019
1	Voltage-Gated Potassium Channels (Voltage-Gated Potassium Channel)IBA 05/2018
1	Brain-Derived Neurotrophic Factor (BDNF)IBA 01/2018
1	Immunologic Factors (Immunomodulators)IBA 01/2018
1	Nerve Growth Factor (NGF)IBA 01/2018
1	Minocycline (Cyclops)FDA LinkGeneric 01/2018
1	Interleukin-10 (Interleukin 10)IBA 01/2018
1	CytokinesIBA 01/2017
1	InterferonsIBA 01/2017
1	LipopolysaccharidesIBA 01/2017
1	Nitric Oxide (Nitrogen Monoxide)FDA Link 01/2017
1	TRAM 34IBA 12/2016
1	Formaldehyde (Formol)FDA Link 01/2015
1	Pyrethrins (Pyrethroids)FDA Link 04/2014
1	bifenthrinIBA 04/2014
1	Proteins (Proteins, Gene)FDA Link 03/2013
1	Myelin-Oligodendrocyte GlycoproteinIBA 06/2012

Therapy/Procedure

3	Therapeutics 01/2018 - 06/2012
1	Ligation 01/2015
1	Immunomodulation 09/2014